Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
Oliu-Barton, Miquel; Pradelski, Bary; Algan, Yann; Baker, Michael G.; Binagwaho, Agnes; Dore, Gregory J.; El-Mohandes, Ayman; Fontanet, Arnaud; Peichl, Andreas; Priesemann, Viola; Wolff, Guntram B.; Yamey, Gavin; Lazarus, Jeffrey V. (2022), Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines, The Lancet Global Health, 10, 1, p. e142-e147. 10.1016/S2214-109X(21)00494-0
Type
Article accepté pour publication ou publiéDate
2022Journal name
The Lancet Global HealthVolume
10Number
1Publisher
Elsevier
Pages
e142-e147
Publication identifier
Metadata
Show full item recordAuthor(s)
Oliu-Barton, MiquelCEntre de REcherches en MAthématiques de la DEcision [CEREMADE]
Pradelski, Bary
Performance analysis and optimization of LARge Infrastructures and Systems [POLARIS ]
Algan, Yann

Ecole des Hautes Etudes Commerciales [HEC Paris]
Baker, Michael G.
University of Otago [Dunedin, Nouvelle-Zélande]
Binagwaho, Agnes

Department of Global Health, University of Global Health Equity, Kigali, Rwanda
Dore, Gregory J.
The Kirby Institute for Infection and Immunity in Society [UNSW]
El-Mohandes, Ayman
City University of New York [New York] [CUNY]
Fontanet, Arnaud
Pasteur-Cnam Risques infectieux et émergents [PACRI]
Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology
Peichl, Andreas
Ludwig-Maximilians University [Munich] [LMU]
Priesemann, Viola
Max Planck Institute for Dynamics and Self-Organization [MPIDS]
Wolff, Guntram B.
Esade Centre for Economic Policy [Madrid] [EsadeEcPol]
Yamey, Gavin
DUKE UNIVERSITY DURHAM USA
Lazarus, Jeffrey V.
Barcelona Institute for Global Health [Barcelona, Spain] [ISGlobal]
Abstract (EN)
There is increasing evidence that elimination strategies have resulted in better outcomes for public health, the economy, and civil liberties than have mitigation strategies throughout the first year of the COVID-19 pandemic. With vaccines that offer high protection against severe forms of COVID-19, and increasing vaccination coverage, policy makers have had to reassess the trade-offs between different options. The desirability and feasibility of eliminating SARS-CoV-2 compared with other strategies should also be re-evaluated from the perspective of different fields, including epidemiology, public health, and economics. To end the pandemic as soon as possible-be it through elimination or reaching an acceptable endemic level-several key topics have emerged centring around coordination, both locally and internationally, and vaccine distribution. Without coordination it is difficult if not impossible to sustain elimination, which is particularly relevant in highly connected regions, such as Europe. Regarding vaccination, concerns remain with respect to equitable distribution, and the risk of the emergence of new variants of concern. Looking forward, it is crucial to overcome the dichotomy between elimination and mitigation, and to jointly define a long-term objective that can accommodate different political and societal realities.Related items
Showing items related by title and author.
-
Oliu-Barton, Miquel; Pradelski, Bary; Algan, Yann; Baker, Michael G.; Binagwaho, Agnes; Dore, Gregory J.; El-Mohandes, Ayman; Fontanet, Arnaud; Peichl, Andreas; Priesemann, Viola; Wolff, Guntram B.; Yamey, Gavin; Lazarus, Jeffrey V. (2022) Article accepté pour publication ou publié
-
Oliu-Barton, Miquel; Pradelski, Bary; Woloszko, Nicolas; Guetta-Jeanrenaud, Lionel; Aghion, Philippe; Artus, Patrick; Fontanet, Arnaud; Martin, Philippe; Wolff, Guntram B. (2022) Article accepté pour publication ou publié
-
Oliu Barton, Miquel; Pradelski, Bary (2021) Article accepté pour publication ou publié
-
Oliu-Barton, Miquel (2015) Article accepté pour publication ou publié
-
Oliu-Barton, Miquel; Gensbittel, Fabien (2020) Article accepté pour publication ou publié